News       Events               CHITIN

 

COVID-19 Rapid Response Funding Call

HSC R&D Division supports research studies that address the current COVID-19 pandemic. 

TITLE CHIEF INVESTIGATOR DATES         COST TO HSC R&D 

Repurposing FDA-approved drugs for treatment of 2019-nCoV-induced disease.

 

Professor Ultan Power (QUB) 2020-21 £208,070

Necessary discussions: Advance care planning for nursing homes in a COVID-19 outbreak  (Awarded co-funded with UKRI ESRC)

 

Professor Kevin Brazil (QUB) 2020-21 £131,697

A mixed methods study of the community pharmacy workforce’s preparedness for, and response to, the COVID-19 pandemic

 

Professor Carmel Hughes (QUB) 2020-21 £63,829

Effectiveness of staff well-being interventions in response to COVID-19 in Northern Ireland

 

Dr Ciaran Shannon (NHSCT) 2020-21 £68,274

The REALIST Study (Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration): Re-purposed  to recruit patients with ARDS secondary to COVID-19

Click here for press release**

Professor Danny McAuley (QUB/BHSCT) 2020-21 £282,736

A survey of hospital dialysis patients during the COVID-19 pandemic in Northern Ireland

Click here for Short Report**

Professor Joanne Reid (QUB) 2020 £4,993

COVID-19 Possible options for analysis and intervention via social media

 

Professor Frank Kee (QUB) 2020-21 £42,000

Modulation of the innate immune response to SARS-CoV-2 with bradykinin inhibition

 

Dr Joe Kidney (BHSCT) 2020-21 £78,500

Health & Social Care Workers’ quality of working life and coping while working during COVID-19 Pandemic

 

Dr Paula McFadden (UU) 2020-21 £70,000

Seroprevalence of SARS-Cov-2 infection in healthy children across the UK

 

Dr Thomas Waterfield (QUB) 2020 £18,750